Side-by-Side Comparison · 2026

Dulaglutide vs Mazdutide

Dulaglutide vs Mazdutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

Dulaglutide
Metabolic & Mitochondrial

Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes and for reducing cardiovascular events in adults with T2DM or cardiovascular risk factors. It is an Fc-fusion protein consisting of two modified GLP-1 molecule...

Calculate Dulaglutide dose →
Mazdutide
Metabolic & Mitochondrial

Mazdutide (IBI362) is a once-weekly GLP-1/glucagon receptor dual agonist developed by Innovent Biologics. By activating both receptors simultaneously, it combines the appetite suppression and insulin-sensitizing effects of GLP-1 agonism with the fat-oxidizing and energy-expenditu...

Calculate Mazdutide dose →
Key Parameters
Parameter Dulaglutide Mazdutide
Category Metabolic & Mitochondrial Metabolic & Mitochondrial
Research FDA Approved Phase III (China)
Half-Life ~5 days ~7 days
Typical Dose 0.75–4.5 mg 3–9 mg
Frequency Once weekly Once weekly
Route Subcutaneous (weekly) Subcutaneous (weekly)
FDA Status Approved Not Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Frequently Asked Questions
What is the difference between Dulaglutide and Mazdutide?
Dulaglutide: Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes and for reducing cardiovascular events in adults with T2DM or cardiovascular ri... Mazdutide: Mazdutide (IBI362) is a once-weekly GLP-1/glucagon receptor dual agonist developed by Innovent Biologics. By activating both receptors simultaneously, it combines the appetite suppression and insulin-...
Which has a longer half-life, Dulaglutide or Mazdutide?
Dulaglutide half-life: ~5 days. Mazdutide half-life: ~7 days.
Can you stack Dulaglutide and Mazdutide?
Dulaglutide and Mazdutide are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.